When we challenge boundaries,  we advance interventional radiology.
Logo When we challenge boundaries, we advance interventional radiology

Interventional Radiology

Image of lab: Helping advance the treatment of cancer patients worldwide.

Committed to Interventional Oncology

Boston Scientific is committed to advancing the treatment of cancer and other complex interventional procedures worldwide. 
TheraSphere receives FDA Approval.

TheraSphere receives FDA Approval!

After 20 years as a humanitarian exemption device (HDE), the FDA grants TheraSphere pre-market approval, making TheraSphere the only Y-90 therapy indicated for HCC. This means institutional review board (IRB) approval of TheraSphere is no longer required by the FDA. 
Eluvia™ Drug-Eluting Stent  and Ranger™ Drug-Coated Balloon

Eluvia Drug-Eluting Stent and Ranger Drug-Coated Balloon

Boston Scientific is committed to advancing science in the fight against PAD. Our proven results are backed by Level-1 Randomized Controlled Trials.


Resources for patients and healthcare professionals.

Product Catalogs

View and download the coronary and peripheral vascular product catalogs.
Talk to a representative icon.

Talk to a representative

Want to learn more about products and services? One of our sales representatives will be happy to contact you.

Get updates icon.

Get updates

Stay up-to-date with emails on the latest advances, news and innovations in interventional radiology.

Sign up for training icon.

Sign up for training

Our specialized training and expert support focuses on improving your skills.



TheraSphere is a registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd., a wholly owned subsidiary of Boston Scientific Corporation.